A Review on Classification of White Blood Cells Using Machine Learning Models

The machine learning (ML) and deep learning (DL) models contribute to exceptional medical image analysis improvement. The models enhance the prediction and improve the accuracy by prediction and classification. It helps the hematologist to diagnose the blood cancer and brain tumor based on calculations and facts. This review focuses on an in-depth analysis of modern techniques applied in the domain of medical image analysis of white blood cell classification. For this review, the methodologies are discussed that have used blood smear images, magnetic resonance imaging (MRI), X-rays, and similar medical imaging domains. The main impact of this review is to present a detailed analysis of machine learning techniques applied for the classification of white blood cells (WBCs). This analysis provides valuable insight, such as the most widely used techniques and best-performing white blood cell classification methods. It was found that in recent decades researchers have been using ML and DL for white blood cell classification, but there are still some challenges. 1) Availability of the dataset is the main challenge, and it could be resolved using data augmentation techniques. 2) Medical training of researchers is recommended to help them understand the structure of white blood cells and select appropriate classification models. 3) Advanced DL networks such as Generative Adversarial Networks, R-CNN, Fast R-CNN, and faster R-CNN can also be used in future techniques.Comment: 23 page

Early Detection of Diabetic Retinopathy Based Artificial Intelligent Techniques

The eye is impacted by several disorders, either directly or indirectly. As a result, eye exams are a crucial component of general healthcare. One of the effects of diabetes is diabetic retinopathy (DR), which affects the blood vessels that supply and nourish the retina and causes severe visual loss. One of the prevalent eye conditions and a consequence of diabetes that affects the eyes is diabetic retinopathy. The symptoms of diabetic retinopathy may be absent or minimal. It may eventually result in blindness. Therefore, seeing symptoms early could aid in preventing blindness. This paper aims to research automatic methods for detecting diabetic retinopathy and create a reliable system for doing so. A modified extracted feature for the automatic identification of DR in digital fundus pictures is presented. The properties of exudates, blood vessels, and microaneurysms—three elements of diabetic retinopathy—are reported utilizing a variety of image processing techniques. Back Propagation Neural Networks (BPNN) and Support Vector Machine (SVM) classifiers are used to categorize the phases. SVM, which has accuracy, sensitivity, and specificity of 96.5, 97.2, and 93.3 percent, respectively, is the model that performs the best overall.The eye is impacted by several disorders, either directly or indirectly. As a result, eye exams are a crucial component of general healthcare. One of the effects of diabetes is diabetic retinopathy (DR), which affects the blood vessels that supply and nourish the retina and causes severe visual loss. One of the prevalent eye conditions and a consequence of diabetes that affects the eyes is diabetic retinopathy. The symptoms of diabetic retinopathy may be absent or minimal. It may eventually result in blindness. Therefore, seeing symptoms early could aid in preventing blindness. This paper aims to research automatic methods for detecting diabetic retinopathy and create a reliable system for doing so. A modified extracted feature for the automatic identification of DR in digital fundus pictures is presented. The properties of exudates, blood vessels, and microaneurysms—three elements of diabetic retinopathy—are reported utilizing a variety of image processing techniques. Back Propagation Neural Networks and Support Vector Machine classifiers are used to categorize the phases. SVM, which has accuracy, sensitivity, and specificity of 96.5, 97.2, and 93.3 percent, respectively, is the model that performs the best overall.

Fuzzy Inspired Case based Reasoning for Hematology Malignancies Classification

Conventional approaches for collecting and reporting hematological data as well as diagnosing hematologic malignancies such as leukemia, anemia, e.t.c are based on subjective professional physician personal opinions or experiences which are influenced by human error, dependent on human-to-human judgments, time consuming processes and the blood results are non-reproducible. In the light of those human limitations identified, an automatic or semi-automatic classification and corrective method is required because it reduces the load on human observers and accuracy is not affected due to fatigue. Case-Based Reasoning (CBR) as a multi-disciplinary subject that focuses on the reuse of past experiences or cases to proffer solution to new cases was adopted and combined with the power of Fuzzy logic to design a software model that will effectively mine hematology data. This study aim at helping the medical practitioners to diagnose and provide corrective treatment to both normal patients and patients with hematology disorder at the early stage which can reduce the number of deaths. This aim is achievable by developing an intelligent expert system based on fuzzy logic and case-based reasoning for classification of hematology malignancy

Red Blood Cell Segmentation with Overlapping Cell Separation and Classification on Imbalanced Dataset

Automated red blood cell (RBC) classification on blood smear images helps hematologists to analyze RBC lab results in a reduced time and cost. However, overlapping cells can cause incorrect predicted results, and so they have to be separated into multiple single RBCs before classifying. To classify multiple classes with deep learning, imbalance problems are common in medical imaging because normal samples are always higher than rare disease samples. This paper presents a new method to segment and classify RBCs from blood smear images, specifically to tackle cell overlapping and data imbalance problems. Focusing on overlapping cell separation, our segmentation process first estimates ellipses to represent RBCs. The method detects the concave points and then finds the ellipses using directed ellipse fitting. The accuracy from 20 blood smear images was 0.889. Classification requires balanced training datasets. However, some RBC types are rare. The imbalance ratio of this dataset was 34.538 for 12 RBC classes from 20,875 individual RBC samples. The use of machine learning for RBC classification with an imbalanced dataset is hence more challenging than many other applications. We analyzed techniques to deal with this problem. The best accuracy and F1-score were 0.921 and 0.8679, respectively, using EfficientNet-B1 with augmentation. Experimental results showed that the weight balancing technique with augmentation had the potential to deal with imbalance problems by improving the F1-score on minority classes, while data augmentation significantly improved the overall classification performance.Comment: This work has been submitted to the Heliyon for possible publication. Copyright may be transferred without notice, after which this version may no longer be accessibl

Role of machine learning in early diagnosis of kidney diseases.

Machine learning (ML) and deep learning (DL) approaches have been used as indispensable tools in modern artificial intelligence-based computer-aided diagnostic (AIbased CAD) systems that can provide non-invasive, early, and accurate diagnosis of a given medical condition. These AI-based CAD systems have proven themselves to be reproducible and have the generalization ability to diagnose new unseen cases with several diseases and medical conditions in different organs (e.g., kidneys, prostate, brain, liver, lung, breast, and bladder). In this dissertation, we will focus on the role of such AI-based CAD systems in early diagnosis of two kidney diseases, namely: acute rejection (AR) post kidney transplantation and renal cancer (RC). A new renal computer-assisted diagnostic (Renal-CAD) system was developed to precisely diagnose AR post kidney transplantation at an early stage. The developed Renal-CAD system perform the following main steps: (1) auto-segmentation of the renal allograft from surrounding tissues from diffusion weighted magnetic resonance imaging (DW-MRI) and blood oxygen level-dependent MRI (BOLD-MRI), (2) extraction of image markers, namely: voxel-wise apparent diffusion coefficients (ADCs) are calculated from DW-MRI scans at 11 different low and high b-values and then represented as cumulative distribution functions (CDFs) and extraction of the transverse relaxation rate (R2*) values from the segmented kidneys using BOLD-MRI scans at different echotimes, (3) integration of multimodal image markers with the associated clinical biomarkers, serum creatinine (SCr) and creatinine clearance (CrCl), and (4) diagnosing renal allograft status as nonrejection (NR) or AR by utilizing these integrated biomarkers and the developed deep learning classification model built on stacked auto-encoders (SAEs). Using a leaveone- subject-out cross-validation approach along with SAEs on a total of 30 patients with transplanted kidney (AR = 10 and NR = 20), the Renal-CAD system demonstrated 93.3% accuracy, 90.0% sensitivity, and 95.0% specificity in differentiating AR from NR. Robustness of the Renal-CAD system was also confirmed by the area under the curve value of 0.92. Using a stratified 10-fold cross-validation approach, the Renal-CAD system demonstrated its reproduciblity and robustness with a diagnostic accuracy of 86.7%, sensitivity of 80.0%, specificity of 90.0%, and AUC of 0.88. In addition, a new renal cancer CAD (RC-CAD) system for precise diagnosis of RC at an early stage was developed, which incorporates the following main steps: (1) estimating the morphological features by applying a new parametric spherical harmonic technique, (2) extracting appearance-based features, namely: first order textural features are calculated and second order textural features are extracted after constructing the graylevel co-occurrence matrix (GLCM), (3) estimating the functional features by constructing wash-in/wash-out slopes to quantify the enhancement variations across different contrast enhanced computed tomography (CE-CT) phases, (4) integrating all the aforementioned features and modeling a two-stage multilayer perceptron artificial neural network (MLPANN) classifier to classify the renal tumor as benign or malignant and identify the malignancy subtype. On a total of 140 RC patients (malignant = 70 patients (ccRCC = 40 and nccRCC = 30) and benign angiomyolipoma tumors = 70), the developed RC-CAD system was validated using a leave-one-subject-out cross-validation approach. The developed RC-CAD system achieved a sensitivity of 95.3% ± 2.0%, a specificity of 99.9% ± 0.4%, and Dice similarity coefficient of 0.98 ± 0.01 in differentiating malignant from benign renal tumors, as well as an overall accuracy of 89.6% ± 5.0% in the sub-typing of RCC. The diagnostic abilities of the developed RC-CAD system were further validated using a randomly stratified 10-fold cross-validation approach. The results obtained using the proposed MLP-ANN classification model outperformed other machine learning classifiers (e.g., support vector machine, random forests, and relational functional gradient boosting) as well as other different approaches from the literature. In summary, machine and deep learning approaches have shown potential abilities to be utilized to build AI-based CAD systems. This is evidenced by the promising diagnostic performance obtained by both Renal-CAD and RC-CAD systems. For the Renal- CAD, the integration of functional markers extracted from multimodal MRIs with clinical biomarkers using SAEs classification model, potentially improved the final diagnostic results evidenced by high accuracy, sensitivity, and specificity. The developed Renal-CAD demonstrated high feasibility and efficacy for early, accurate, and non-invasive identification of AR. For the RC-CAD, integrating morphological, textural, and functional features extracted from CE-CT images using a MLP-ANN classification model eventually enhanced the final results in terms of accuracy, sensitivity, and specificity, making the proposed RC-CAD a reliable noninvasive diagnostic tool for RC. The early and accurate diagnosis of AR or RC will help physicians to provide early intervention with the appropriate treatment plan to prolong the life span of the diseased kidney, increase the survival chance of the patient, and thus improve the healthcare outcome in the U.S. and worldwide

Intelligent technologies for real-time monitoring and decision support systems

MPhilAutomation of data processing and control of operations involving intelligent technologies that is considered the next generation technology requires error-free data capture systems in both clinical research and healthcare. The presented research constitutes a step in the development of intelligent technologies in healthcare. The proposed improvement is by automation that includes the elements of intelligence and prediction. In particular automatic data acquisition systems for several devices are developed including pervasive computing technologies for mobility. The key feature of the system is the minimisation/near eradication of erroneous data input along with a number of other security measures ensuring completeness, accuracy and reliability of the patients‟ data. The development is based on utilising existing devices to keep the cost of Data Acquisition Systems down. However, with existing technology and devices one can be limited to features required to perform more refined analysis. Research of existing and development of a new device for assessment of neurological diseases, such as MS (Multiple Sclerosis) using Stroop test is performed. The software can also be customized for use in other diseases affecting Central Nervous System such as Parkinson‟s disease. The introduction of intelligent functions into the majority of operations enables quality checks and provides on-line user assistance. It could become a key tool in the first step of patient diagnosis before referring to more advanced tests for further investigation. Although the software cannot fully ensure the diagnosis of MS or PD but can make significant contribution in the process of diagnosis and monitorin

LABRAD : Vol 46, Issue 4 - October 2021

Role of Barcoding in a Clinical Laboratory to Reduce Pre-Analytical Errors Congenital Dyserythropoietic Anemia: The Morphological Diagnosis Digital Imaging in Hematology: A New Beginning Metabolomics: Identification of Fatty Acid Oxidation (FAO) Disorders Next-Generation Sequencing for HLA Genotyping Urine Metabolomics to identify Organic Academia Next-Generation Sequencing (NGS) of Solid Tumor Importance of using Genomic Tool in Microbial Identification Radiology Practice in 21st Century: Role of Artificial Intelligence Case Quiz Best of the Recent Past Polaroidhttps://ecommons.aku.edu/labrad/1036/thumbnail.jp

Rede neural convolucional eficiente para detecção e contagem dos glóbulos sanguíneos

Blood cell analysis is an important part of the health and immunity assessment. There are three major components of the blood: red blood cells, white blood cells, and platelets. The count and density of these blood cells are used to find multiple disorders like blood infections (anemia, leukemia, among others). Traditional methods are time-consuming, and the test cost is high. Thus, it arises the need for automated methods that can detect different kinds of blood cells and count the number of cells. A convolutional neural network-based framework is proposed for detecting and counting the cells. The neural network is trained for the multiple iterations, and a model having lower validation loss is saved. The experiments are done to analyze the performance of the detection system and results with high accuracy in the counting of the cells. The mean average precision is achieved when compared to ground truth provided to respective labels. The value of the average precision is found to be ranging from 70% to 99.1%, with a mean average precision value of 85.35%. The proposed framework had much less time complexity: it took only 0.111 seconds to process an image frame with dimensions of 640×480 pixels. The system can also be implemented in low-cost, single-board computers for rapid prototyping. The efficiency of the proposed framework to identify and count different blood cells can be utilized to assist medical professionals in finding disorders and making decisions based on the obtained report.El análisis de células sanguíneas es una parte importante de la evaluación de la salud y la inmunidad. Hay tres componentes principales de los glóbulos rojos, los glóbulos blancos y las plaquetas. El recuento y la densidad de estas células sanguíneas se utilizan para encontrar múltiples trastornos como infecciones de la sangre como anemia, leucemia, etc. Los métodos tradicionales consumen mucho tiempo y el costo de las pruebas es alto. Por tanto, surge la necesidad de métodos automatizados que puedan detectar diferentes tipos de células sanguíneas y contar el número de células. Se propone un marco basado en una red neuronal convolucional para la detección y el recuento de las células. La red neuronal se entrena para las múltiples iteraciones y se guarda un modelo que tiene una menor pérdida de validación. Los experimentos se realizan con el fin de analizar el rendimiento del sistema de detección y los resultados con alta precisión en el recuento de células. La precisión promedio se logra al analizar las respectivas etiquetas que hay en la imagen. Se ha determinado que el valor de la precisión promedio, oscila entre el 70% y el 99,1% con un valor medio de 85,35%. El coste computacional de la propuesta fue de 0.111 segundos, procesar una imagen con dimensiones de 640 × 480 píxeles. El sistema también se puede implementar en ordenadores con CPU de bajo costo, para la creación rápida de prototipos. La eficiencia de la propuesta, para identificar y contar diferentes células sanguíneas, se puede utilizar para ayudar a los profesionales médicos a encontrar los trastornos y la toma decisiones, a partir de la identificación automática.O exame de células sanguíneas é uma parte importante da avaliação de saúde e imunidade. Há três componentes principais dos glóbulos vermelhos, glóbulos brancos e plaquetas. A contagem e a densidade dessas células sanguíneas são usadas para encontrar múltiplos distúrbios, tais como infecções no sangue: anemia, leucemia, etc. Os métodos tradicionais são demorados e o custo dos testes é alto. Portanto, surge a necessidade de métodos automatizados que possam detectar diferentes tipos de células sanguíneas e contar o número de células. É proposta uma estrutura baseada em rede neural convolucional para a detecção e contagem de células. A rede neural é treinada para múltiplas iterações e é salvo um modelo que tem uma menor perda de validação. São realizados experimentos para analisar o desempenho do sistema de detecção e os resultados com alta precisão na contagem de células. A precisão média é obtida analisando os respectivos rótulos na imagem. Foi determinado que o valor médio de precisão oscila entre 70 % e 99,1 % com um valor médio de 85,35 %. O custo computacional da proposta foi de 0,111 segundos, processando uma imagem com dimensões de 640 × 480 pixels. O sistema também pode ser implementado em computadores com CPUs de baixo custo para prototipagem rápida. A eficiência da proposta, para identificar e contar diferentes células sanguíneas, pode ser usada para ajudar os profissionais médicos a encontrar distúrbios e tomar decisões, com base na identificação automática